Clinical Trials Logo

Clinical Trial Summary

Investigators recently developed the APPROACH electronic patient reported outcome (ePROM) Survey and Clinician Report tools to collect individual results from online quality of life and health status surveys for patients with coronary heart disease, and report them back to their treating clinicians. This pilot interventional study uses a pre-post design to assess whether implementing the ePROM system into routine care is feasible and acceptable to patients and physicians, and to inform feasibility for a larger clinical trial. Specifically, the investigators aim to evaluate use of the ePROM Patient Survey and Clinician Report among eligible outpatients with known or suspected coronary artery disease and their cardiologists. Additionally, the investigators aim to determine if the use of the APPROACH ePROMs Clinician Report in routine medical encounters is acceptable (based on administrative burden, ease of use, and time required) to patients and clinicians, and supports effective communication for management of symptoms of coronary artery disease.


Clinical Trial Description

Background Electronic capture and reporting of patient reported outcome measures has the potential to improve patient-physician communication and the delivery of cardiac care for patients with chronic health conditions, including coronary artery disease.[1, 2] Input from both patients and clinicians was used to develop an ePROMs Patient Survey and a Clinician Report that summarizes and contextualizes the responses for patients with coronary artery disease. The investigators plan to perform a staged implementation of both aspects for patients attending cardiac catheterization labs in Alberta and evaluate the impact of this intervention on patient outcomes and use of health services in a randomized clinical trial. However, before proceeding with this large-scale trial, the investigators need to ensure that the intervention can be delivered effectively and assess its impact on the processes of care. This pilot study is designed to assess the perceived utility of the APPROACH ePROM Clinician Report in routine clinical care and to inform feasibility for a larger clinical trial. Methods Design: Prospective, pre-post intervention clinical study. Setting: Outpatient cardiology practices in Alberta. Study Design: In each cardiology practice, control group patients for 4 months or until 30 patients are enrolled, whichever is soonest. Once the control group enrolment target is reached in each practice, a formal training program covering the use of the ePROM Clinician Report will be delivered to each cardiologist. The practice will then transition to the intervention period. The intervention period will last 4 months or until 30 patients have been enrolled, whichever is soonest. Each patient will contribute a single visit, with no longitudinal follow-up. Study Procedures - Control Period: - Eligible patients in each participating clinician practice will be enrolled before providing the ePROMs intervention to establish the baseline level for several study measures, including satisfaction with care and level of communication (see Outcomes section below). - Patient Screening and Recruitment. Patients who have an upcoming outpatient visit with a study cardiologist in the next 14-28 days will be screened by the cardiologist's office staff, who will obtain the patient's consent to be contacted by the research team. Research personnel will confirm study eligibility an\d then contact patients by telephone to explain the study and obtain their informed consent, as well as collecting baseline demographic (age, sex, ethnicity, education, employment), clinical (cardiac and non-cardiac medical history) and health literacy data. Patients will be asked to provide an email address for the purposes of receiving study communications. - Pre-visit intervention: Control period patients will not receive the ePROMs survey to complete, and will not be further contacted by study personnel in advance of their cardiologist clinic visit. - Post-visit data collection. Control period patients will be sent an electronic survey within 48 hours after their scheduled clinic visit, with a reminder phone call 4-7 days later to those who have not yet completed it. The survey will consist of the following components: Assessment of communication effectiveness for the visit, using the Communication Assessment Tool, and assessment of patient satisfaction with care at the study visit. Study Procedures - Intervention period: - Clinician Training. Participating cardiologists will provide informed consent for study participation and receive one-on-one training on the use and interpretation of the ePROMs Clinician Report prior to starting patient enrolment. Training will be conducted by research personnel and will include didactic components outlining the potential value of PROMs in routine care, interpretation of the report itself, and a list of potential resources for patients with non-cardiac concerns identified by the ePROMs tool. Research personnel will also provide information, training, and ongoing support to each participating cardiologist's office staff to ensure the success of screening and recruitment. - Patient Screening and Recruitment. The initial screening, recruitment, and baseline data collection process will be identical to that for the control period. Patient Survey. Consenting patients will be sent an email link to the APPROACH ePROM survey at least 7 days before their upcoming cardiologist appointment, and will be asked to complete it at least 72 hours before their appointment. The APPROACH ePROM survey consists of several well validated PROM instruments, including the Seattle Angina Questionnaire 7-item version,[4] the EuroQol EQ5D-5L,[5] the Medical Outcomes Study Social Support Scale (8 item version),[6] the Patient Health Questionnaire 2-item and 9-item (PHQ2/9) depression screening tools[7], and the Self-Care of Coronary Heart Disease Inventory (SC-CHDI-V3).[8] To improve the survey completion rate, research staff will follow-up by telephone with the patient in the week before the clinic visit to offer support and a single system-generated reminder email will be sent 72 hours before the appointment. Patients who do not complete the survey in advance of the visit will be offered the opportunity to complete it while waiting for their appointment on a study-supplied iPad. - Clinician Report. The research team will transmit the ePROM Clinician Report for each patient to the cardiologist's office in advance of the visit, using their preferred method (fax/email). Participating cardiologists will be sent weekly reminder emails to encourage them to use the reports, and to request any feedback on the study to date. Sample size and statistical considerations This pilot study will use convenience sampling with no powered statistical inference testing planned. The investigators estimate that a total sample of 4 cardiologists and approximately 80 control group and 120 intervention group patients are needed to achieve the objectives of estimating the uptake and perceived acceptability / utility of both the ePROM Patient Survey and Clinician Report. Expected outcomes At the conclusion of this pilot study, the investigators will have an increased understanding of: - A comparison of patient assessments of communication effectiveness and overall satisfaction of care before and after introduction of the ePROMs surveys and clinician reports. - Both clinicians' and patients' perceptions about the acceptability and utility of ePROM Clinician Report as an adjunct to routine care for patients with coronary artery disease. - The barriers and facilitators involved with implementing ePROMs Clinician Report in ambulatory care practices in Alberta. - The overall and item-level completeness of the ePROM Patient Surveys. - Preliminary estimates of the frequency with which the ePROM Clinician Report leads to a change in management of both cardiac and non-cardiac clinical concerns. Limitations, Anticipated Risks and mitigation plan: Recruitment of cardiology practices for the pilot. The research team includes cardiologists in both Calgary and Edmonton. The investigators will recruit from their colleagues, who have generally been supportive of other pilot activities in this area. The investigators will request basic information about their practice, including the frequency of clinics and case mix, prior to confirming their participation. Recruitment of patients within clinics. The research team will provide significant training and ongoing support to the office staff at each clinic in order to encourage them to identify potential patients and perform the consent to contact activities. Ensuring timely distribution of Clinician Report to clinics. The investigators will establish clinic-specific processes to ensure that the reports are received in the most convenient way for each participating clinic, with sufficient time for them to be incorporated into the medical record for review by the physician. Reliance on self-report for measuring uptake of the clinician report. This study design does not have an objective measure of the use of the Clinician Report in each encounter. Directly observing encounters is not feasible. Therefore, the investigators are relying on patient self-report, which has limitations in terms of potential recall bias. The research team is mitigating this bias by performing the post-encounter survey as close to the visit as is feasible, and by comparing with a control period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06164457
Study type Interventional
Source University of Calgary
Contact Stephen B WIlton, MD, MSc
Phone 4032207102
Email sbwilton@ucalgary.ca
Status Not yet recruiting
Phase N/A
Start date January 2024
Completion date September 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A